NLRP3 and cancer: When we reactivated the NLRP3 inflammasome in OSCC cells, the malignancy inhibited by SOAT1 knockdown was recovered, confirming that NLRP3 inflammasome as the downstream of SOAT1 play a vicious role for cancer progression.